-+ 0.00%
-+ 0.00%
-+ 0.00%

MABWELL ANNOUNCES ACCEPTANCE OF SUPPLEMENTAL BIOLOGICS LICENSE APPLICATION BY NMPA FOR MAIWEIJIAN (DENOSUMAB)

Reuters·04/16/2026 00:00:00

Please log in to view news